MPV17
Basic information
Region (hg38): 2:27309492-27325680
Links
Phenotypes
GenCC
Source:
- mitochondrial DNA depletion syndrome 6 (hepatocerebral type) (Strong), mode of inheritance: AR
- mitochondrial DNA depletion syndrome 6 (hepatocerebral type) (Supportive), mode of inheritance: AR
- Charcot-Marie-Tooth disease, axonal, type 2EE (Strong), mode of inheritance: AR
- mitochondrial DNA depletion syndrome 6 (hepatocerebral type) (Strong), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | AR | Biochemical; Gastrointestinal; Oncologic | Glycemic control (eg, with cornstarch) has been shown to slow the progression of hepatic disease; Liver transplanation has been described, though the efficacy is unclear; Awareness of the possible risk of hepatocellular carcinoma may be beneficial | Biochemical; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic | 16909392; 16582910; 18695062; 19520594; 19012992; 20074988; 21511859; 22508010; 22593919; 26437932; 30298599 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (22 variants)
- Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) (12 variants)
- Charcot-Marie-Tooth disease, axonal, type 2EE (7 variants)
- MPV17-related disorder (4 variants)
- Charcot-Marie-Tooth disease, axonal, type 2EE;Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) (4 variants)
- Mitochondrial DNA depletion syndrome (3 variants)
- Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) (2 variants)
- Mitochondrial disease (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MPV17 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 63 | 66 | ||||
missense | 13 | 44 | 61 | |||
nonsense | 13 | 21 | ||||
start loss | 0 | |||||
frameshift | 12 | 10 | 23 | |||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 17 | 22 | ||||
splice region | 2 | 4 | 20 | 26 | ||
non coding | 17 | 58 | 79 | |||
Total | 27 | 56 | 66 | 122 | 4 |
Highest pathogenic variant AF is 0.0000789
Variants in MPV17
This is a list of pathogenic ClinVar variants found in the MPV17 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-27309499-T-G | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) • Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | Uncertain significance (Jan 12, 2018) | ||
2-27309545-C-T | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | Uncertain significance (Jan 13, 2018) | ||
2-27309546-G-A | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | Uncertain significance (Jan 13, 2018) | ||
2-27309552-C-G | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) • Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | Uncertain significance (Jan 12, 2018) | ||
2-27309561-G-A | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | Uncertain significance (Mar 30, 2018) | ||
2-27309565-G-A | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) • Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | Uncertain significance (Jan 13, 2018) | ||
2-27309683-A-G | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | Likely benign (Jan 12, 2018) | ||
2-27309718-C-T | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) • Mitochondrial DNA depletion syndrome | Uncertain significance (Jan 13, 2018) | ||
2-27309724-T-C | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | Uncertain significance (Jan 13, 2018) | ||
2-27309782-C-A | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) • Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | Uncertain significance (Jan 12, 2018) | ||
2-27309832-G-A | Mitochondrial DNA depletion syndrome • Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | Uncertain significance (Jan 12, 2018) | ||
2-27309840-T-G | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | Uncertain significance (Jan 13, 2018) | ||
2-27309851-TCTGACCGTTCCAGGGTCAAGCTGCATCACTGCAAGGTGGAAACGATGGAGTGAGGCAGGCTTAGAGCCGATGTGCCTTCCAGGACAGGTAGGAGTTCCAGATAACAGCAACACATTGGACAACGGCCAACCTAAGGAACAGGAATAAC-T | Pathogenic (Nov 01, 2023) | |||
2-27309858-G-A | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | Uncertain significance (Jan 12, 2018) | ||
2-27309878-C-T | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) • Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | Uncertain significance (Jan 13, 2018) | ||
2-27309900-A-C | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | Conflicting classifications of pathogenicity (May 21, 2018) | ||
2-27309901-G-C | not specified | Likely benign (Sep 08, 2016) | ||
2-27309903-G-A | MPV17-related disorder | Likely benign (Sep 08, 2022) | ||
2-27309915-G-A | Likely benign (Apr 25, 2022) | |||
2-27309916-A-G | Uncertain significance (Sep 17, 2021) | |||
2-27309919-C-G | Uncertain significance (Apr 14, 2023) | |||
2-27309919-C-T | Inborn genetic diseases | Conflicting classifications of pathogenicity (Mar 01, 2024) | ||
2-27309920-G-A | Inborn genetic diseases | Uncertain significance (Jun 22, 2023) | ||
2-27309920-G-T | Likely benign (Jun 04, 2020) | |||
2-27309924-T-C | Likely benign (Dec 24, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MPV17 | protein_coding | protein_coding | ENST00000380044 | 7 | 16188 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.66e-11 | 0.0238 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.237 | 89 | 95.5 | 0.932 | 0.00000537 | 1110 |
Missense in Polyphen | 17 | 25.218 | 0.67413 | 316 | ||
Synonymous | 0.262 | 36 | 38.1 | 0.946 | 0.00000195 | 363 |
Loss of Function | -0.646 | 14 | 11.6 | 1.20 | 5.13e-7 | 132 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00111 | 0.00110 |
Ashkenazi Jewish | 0.000302 | 0.000298 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000167 | 0.000167 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000331 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in mitochondria homeostasis. May be involved in the metabolism of reactive oxygen species and control of oxidative phosphorylation and mitochondrial DNA (mtDNA) maintenance.;
- Pathway
- Peroxisome - Homo sapiens (human);Metabolism of proteins;Peroxisomal protein import
(Consensus)
Intolerance Scores
- loftool
- 0.402
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 33.97
Haploinsufficiency Scores
- pHI
- 0.107
- hipred
- N
- hipred_score
- 0.325
- ghis
- 0.581
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.261
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mpv17
- Phenotype
- endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; skeleton phenotype; renal/urinary system phenotype;
Zebrafish Information Network
- Gene name
- mpv17
- Affected structure
- iridophore
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- mitochondrial genome maintenance;protein targeting to peroxisome;glomerular basement membrane development;cellular response to reactive oxygen species;homeostatic process;inner ear development;regulation of reactive oxygen species metabolic process
- Cellular component
- cytoplasm;mitochondrion;mitochondrial inner membrane;peroxisome;peroxisomal membrane;cytosol;integral component of membrane
- Molecular function
- molecular_function